A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix(®) and Gardasil(®) Human Papillomavirus Vaccines in 12-15 Year Old Girls

BACKGROUND: The current generation of Human Papillomavirus (HPV) vaccines, Cervarix® and Gardasil®, exhibit a high degree of efficacy in clinical trials against the two high-risk (HR) genotypes represented in the vaccines (HPV16 and HPV18). High levels of neutralizing antibodies are elicited against...

Descripción completa

Detalles Bibliográficos
Autores principales: Draper, Eve, Bissett, Sara L., Howell-Jones, Rebecca, Waight, Pauline, Soldan, Kate, Jit, Mark, Andrews, Nicholas, Miller, Elizabeth, Beddows, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641072/
https://www.ncbi.nlm.nih.gov/pubmed/23650505
http://dx.doi.org/10.1371/journal.pone.0061825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641072/
https://www.ncbi.nlm.nih.gov/pubmed/23650505
http://dx.doi.org/10.1371/journal.pone.0061825

Ejemplares similares